Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-05-30
1992-03-24
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546194, 548515, 514356, 514307, 514412, 514424, 514929, A61K 3144
Patent
active
050989103
ABSTRACT:
The invention relates to combinations of angiotensin-converting enzyme inhibitors with calcium antagonists, processes for their preparation and their use as medicaments.
REFERENCES:
patent: 4374847 (1983-02-01), Gruenfeld
patent: 4404206 (1983-09-01), Vincent et al.
patent: 4508729 (1985-04-01), Vincent et al.
patent: 4525301 (1985-06-01), Henning et al.
patent: 4558064 (1985-12-01), Teetz et al.
patent: 4558065 (1985-12-01), Urbach et al.
patent: 4562202 (1985-12-01), Urbach et al.
patent: 4584294 (1986-04-01), Ruyle
patent: 4587258 (1986-05-01), Gold et al.
patent: 4591598 (1986-05-01), Urbach et al.
patent: 4614805 (1986-09-01), Urbach et al.
patent: 4620012 (1986-10-01), Henning et al.
patent: 4634716 (1987-01-01), Parsons et al.
patent: 4659838 (1987-04-01), Lerch
patent: 4668796 (1987-05-01), Geiger et al.
patent: 4668797 (1987-05-01), Urbach et al.
patent: 4684662 (1987-08-01), Henning et al.
patent: 4691022 (1987-09-01), Henning et al.
patent: 4714708 (1987-12-01), Urbach et al.
patent: 4727160 (1988-02-01), Teetz et al.
patent: 4808573 (1989-02-01), Gold et al.
patent: 4818749 (1989-04-01), Gold et al.
patent: 4822894 (1989-04-01), Geiger et al.
patent: 4831157 (1989-05-01), Gold et al.
Leonard et al., J. Am. Chem. Soc., 77, 439 (1955).
Leonard et al., J. Am. Chem. Soc., 78, 3457 (1956).
Leonard et al., J. Am. Chem. Soc., 78, 3463 (1956).
Leonard et al., J. Am. Chem. Soc., 81, 5627 (1959).
Koelsch et al., J. Org. Chem., 26, 1104 (1961).
Griot et al., Helv. Chem. Acta, 42, 121 (1959).
Bonnett et al., J. Chem. Soc., 2087 (1959).
Battersby et al., J. Chem. Soc., 4333 (1958).
Rosenblatt et al., The Chemistry Of Functional Groups; Supplement F: The Chemistry of Amino, Nitroso and Nitro Compounds And Their Derivatives; Part II, S. Patai, ed., Wiley & Sons: N.Y. 1982, pp. 1100-1104.
L. W. Haynes, Enamines, A. G. Cook, ed., Marcel Decker, Inc.: 1969, pp. 68-79, 261-269, 413.
Fieser & Fieser, Reagents For Organic Synthesis, vol. 1, pp. 644-651 (1967).
Boehme et al., Iminium Salts in Organic Chemistry, Part I (E. C. Taylor, ed.) Wiley & Sons: N.Y., 1976, p. 143.
S. Dayagi et al., The Chemistry Of Functional Groups; The Chemistry Of The Carbon-Nitrogen Double Bond, S. Patai, ed., Wiley & Sons: N.Y., 1970, p. 119.
W. Greenlee et al., J. Med. Chem., 28, 434-442 (1985).
K. Ogawa et al., J. Chem. Soc., Perkin Trans. I, 3031-3035 (1982).
R. Bacon and D. Stewart, J. Chem. Soc. (C), 1384-1387 (1966).
R. Bacon et al., J. Chem. Soc. (C), 1388-1389 (1966).
Patchett et al., Nature, 288, 280-283 (1980).
Booth et al., Chemistry and Industry, 466-467 (1956).
Booth et al., J. Chem. Soc., Part I, 1050-1054 (1959).
Murakoshi et al., Chemical Abstracts, 61, 9465(e) (1964).
Cushman et al., Fed. Proc. 38 (13), 2778-2782 (1979).
Houben-Weyl, Methoden der Organischen Chemie, 7(2b), 1403-1404 (1976).
Katritskaya, Dzh. Lagorskaya Khimia Geterosikl. Soedin., Moskow 1963, pp. 155-158.
Anderson, Jr. et al., J. Org. Chem., 43(1), 54-57 (1978).
Bertho et al., "Synthesen In Der 2-Azabicyclo[0.3.3]-octan-Reihe", Chemische Berichte, 92(7), 2218-2235 (1959).
Farkas et al., J. Org. Chem., 22, 1261-1263 (1957).
Taylor et al., J. Org. Chem., 38(16), 2817-2821 (1973).
Taylor et al., Heterocycles, 25, 343-345 (1987).
English language translation of Mitzlaff et al., Liebig's Ann. Chem., 1713-1733 (1978).
Chem. Berichte 86: 1524-1528 (1953).
Quarterly Reviews 25: 323-341 (1971).
Chem. Abst. 49/1955/3009c.
Becker Reinhard
Henning Rainer
Ruger Wolfgang
Teetz Volker
Urbach Hansjorg
Carr Deborah C.
Dees Jos,e G.
Hoechst Aktiengesellschaft
LandOfFree
Combination of angiotensin-converting enzyme inhibitors with cal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of angiotensin-converting enzyme inhibitors with cal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of angiotensin-converting enzyme inhibitors with cal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2010445